Interestingly, while Dystroglycan localizes to both PV+ and CCK+/CB1R+ inhibitory basket synapses in CA1, only the CCK+/CB1R+ IN population was affected in the dystroglycanopathy models (Früh et al., 2016). The gene discussed is CCK; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.